Evommune, Inc.
EVMN
$21.22
$0.170.81%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.81% | 20.54% | 0.00% | 33.09% | -883.55% |
| Total Depreciation and Amortization | -0.53% | 9.12% | 0.00% | 6.31% | 19.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,684.02% | 290.40% | 0.00% | 200.81% | 61.49% |
| Change in Net Operating Assets | 57.11% | -123.56% | 0.00% | -124.10% | 957.75% |
| Cash from Operations | -9.66% | -6.84% | 0.00% | -159.33% | -78.59% |
| Capital Expenditure | -- | -- | -- | 100.00% | 74.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.33% | 214.08% | 0.00% | -217.81% | 3.36% |
| Cash from Investing | 33.33% | 214.08% | 0.00% | -218.02% | 3.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.65% | -21.74% | 0.00% | -17.13% | -74.19% |
| Issuance of Common Stock | 100.00% | -63.64% | 0.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42,429.61% | -100.61% | 0.00% | 23,056.94% | -80.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 632.02% | -12.13% | 0.00% | -827.76% | -72.82% |